Article
Organon results beat estimates on demand for women heath products, biosimilars
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Organon & Co reported better-than-expected second-quarter results on Tuesday, helped by strong demand for its women's heath products and biosimilar drugs, sending the healthcare firm's shares up about 8%.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value